Truffle capital announces the results of fintech100 ranking !
Truffle Capital announces the results of the 1st Fintech100 ranking, in partnership with Finance Innovation, Groupe BPCE and Sopra Steria
Interview of Philippe Pouletty by Hedwige Chevrillon in "Le Grand Journal de l'Éco" on BFM Business TV
"Radically innovative science solves environment and health issues"
Carbios to build in france its first-of-a-kind manufacturing plant for fully bio-recycled PET
The plant will have a capacity to process 50,000 metric tons of plastic waste per year
RollingFunds raises over 5 million euros
Rollingfunds raises €5m to accelerate the deployment of its credit automation technology.
Truffle launchs the Fintech 100, a ranking of French fintechs and insurtechs
Creation of the Fintech 100 ranking, in partnership with Finance Innovation, Groupe BPCE, Sopra Steria Group and Sopra Banking Software
OBAT, a new investment
Digitizing invoicing and payment for SMEs in the construction sector
Merck KGaA entrusts secretive startup with a mid-stage cancer drug targeting master signaling pathway
A secretive French biotech has imported a drug from Germany’s Merck KGaA that will leapfrog the small company right into mid-stage testing...
Could HIV be cured by tackling ‘bumpy’ CD4 cells? France’s Diaccurate wants to find out
Finding a functional cure to HIV is one of the biggest challenges in modern medicine...
Carmat sells its artificial heart for the first time in Italy
The autonomous bioprosthesis created by the French firm has been implanted on a patient in Naples.
Philippe Pouletty appears in Stanford OTL - 50th Anniversary Annual Report
Philippe Pouletty and his work on polymerase chain reaction (PCR) is featured in the Stanford OTL 50th Anniversary Annual Report
PROMISING PHARMA PLAYS FOR INVESTORS
The success of the messenger RNA vaccines for Covid-19 developed by Pfizer Inc. (PFE) and Moderna...
Holistick raises $5M to boost preclinical development of PFO closure device
Discussion of Abivax Clinical Program involving Covid-19, Ulcerative Colitis, Crohn’s Disease and more
Hartmut Ehrlich and Philippe Pouletty discuss Abivax Pipeline of Clinical Programs involving Covid-19, Ulcerative Colitis, Crohn’s Disease...
Centers for Medicare & Medicaid Services (CMS) grant transitional pass-through (TPT) payment for Stryker's SpineJack® System
CMS announced the SpineJack implantable fracture reduction system qualified for the TPT payment as part of the 2021 Medicare Payment System.
Carbios strengthens its position as a reference shareholder in its subsidiary Carbiolice
The company created by Truffle acquired Limagrain Ingredients' position in Carbiolice, thus increasing its shareholding from 52% to 70%.
Abivax Turns Away Suitors as Lead Drug Starts Covid-19 Tests
Abivax, the French biotech embarking on tests of its lead experimental medicine for Covid-19, has turned away several suitors in recent months.
MEDEOR, Truffle Capital's new BioMedTech Fund, qualified by institutional investors through the Tibi committee
Medeor is among the 24 new funds qualified by the committee of institutional investors set up following the Tibi report.
"19 Hours a day of COVID-19"
"19 Hours a day of COVID-19" live the quarantine with Hartmut J. Ehrlich and Philippe Pouletty. A Truffle Capital mini-serie
Philippe Pouletty and Hartmut J. Ehrlich - ABIVAX - Covid-19 Quarantine
WCBS NewsRadio 880: CEO RADIO
Investors Search for Promising Covid Cures
The race to develop vaccines and treatments to build immunity to the novel coronavirus ...